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Chronic rejection is the most prevalent cause of renal transplant failure in the late post-transplant 
period. The clinical significance of acute rejection episodes on occurrence of chronic rejection is 
controversial. We analyzed 503 cases of the first renal transplantation maintained by calcinurine 
inhibitor for the correlation of acute rejection and clinical chronic rejection. The later the first episode 
of acute rejection occurred， the shorter was the half-life of graft. The acute rejection occurring within 3 
post-transplant months worsens long-term graft survival if the peak creatinine level exceeds 2 mg/dl 
Multivariate analysis by the Cox proportional hazard model for factors affecting cadaver graft loss by 
chronic rejection， revealed that the risk factor of acute early rejection was lower than those of donor age 
and post-transplant hypertension. 
(Acta Urol. ]pn. 48: 687-691， 2002) 


































































Recipient age (average +/-S.D.) 
Donor age (a，:crage +/-S.D.) 
Original disease 
Nephritis & Nephrosis 





Immunosuppressant CY A/TAC 
HLA mismatches (average) 












Warm ishemic time (Mins) 
Total ishemic time (Hrs) 
Follow-up months (average+/-S.D.) 
230/110 





































































に与える影響 (Fig.1， 2). 
Table 2. Causes of graft loss of cadaver and living transplantation 
Ca use of graft loss Cadaver (%) Living donor (%) 
Chronic rejection 89 65.4% 29 65.9% 
Chronic rejection & conpliαtion 6 4.4% 2.3% 
Acute on chronic rejection 16 11.8% 2 4.5% 
(Subtotal 81.6% 72.7%) 
Discontinuation of immuno-suppression due to complication 5 3.7% 2.3% 
Death with functioning graft 1 8.1% 3 6.8% 
Reccurence of original disease 5 3.7% 7 15.9% 
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14.5， 7.3， 6.7， 4.0， 4.9， 2.3年，生体腎移植では
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Fig. 3. Percent cadaver graft survivals after the first rejection (left) and their half二life
(right) . 
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Multivariate analysis by Cox proportional hazard model for factors affecting cadaver graft loss 
by chronic rejection 
Table 3. 
95 % confidence limits 
Sig 
Donor age 
Post operative hypertension 
Acute rejection (孟3months) 
Body weight 
HLA同missmatch 
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